Journal Article

DKFZ-2025-02409

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png NETosis in cancer: a critical analysis of the impact of cancer on neutrophil extracellular trap (NET) release in lung cancer patients vs. mice.

Arpinati, L. ; Shaul, M. E. ; Kaisar-Iluz, N. ; Mali, S. ; Mahroum, S. ; Fridlender, Z. G.

2020
Springer Heidelberg

Abstract: Neutrophils play a major role in tumor biology. Among other functions, neutrophils can release extracellular traps (NETs), mesh-like structures of decondensed chromatin fibers, in a process termed NETosis. Originally characterized as an antimicrobial mechanism, NETosis has been described in cancer, but cancer-related predisposition is not clear. In the current study, we investigated the predisposition of circulating neutrophils to release NETs in lung cancer and the impact of G-CSF on this function, comparing circulating neutrophils isolated from cancer patients to the LLC and AB12 mouse models. We find that neutrophils from both healthy donors and cancer patients display high NETotic potential, with 30-60% of cells undergoing NETosis upon PMA stimulation. In contrast, neutrophils isolated from tumor-bearing mice displayed only 4-5% NETotic cells, though significantly higher than naive controls (1-2%). Despite differential mechanisms of activation described, Ionomycin and PMA mainly triggered suicidal rather than vital NETosis. G-CSF secreting tumors did not increase NETotic rates in murine neutrophils, and direct G-CSF stimulation did not promote their NET release. In contrast, human neutrophils strongly responded to G-CSF stimulation resulting also in a higher response to PMA + G-CSF stimulation. Our data show clear differences in NETotic potentials between human and murine neutrophils. We do not find a predisposition of neutrophils to release NETs in lung cancer patients compared to healthy controls, whereas cancer may modulate neutrophils' NETotic potential in mice. G-CSF secreted from tumors differentially affects murine and human NETosis in cancer. These important differences should be considered in future studies of NETosis in cancer.

Keyword(s): Animals (MeSH) ; Cell Line, Tumor (MeSH) ; Extracellular Traps: drug effects (MeSH) ; Extracellular Traps: physiology (MeSH) ; Granulocyte Colony-Stimulating Factor: pharmacology (MeSH) ; Humans (MeSH) ; Ionomycin: pharmacology (MeSH) ; Lung Neoplasms: immunology (MeSH) ; Mice (MeSH) ; Mice, Inbred BALB C (MeSH) ; Mice, Inbred C57BL (MeSH) ; Neutrophils: physiology (MeSH) ; Tetradecanoylphorbol Acetate: pharmacology (MeSH) ; CITIM 2019 ; G-CSF ; Lung cancer ; Netosis ; Neutrophils ; Granulocyte Colony-Stimulating Factor ; Ionomycin ; Tetradecanoylphorbol Acetate

Note: #DKFZ-MOST-Ca181#

---

---

Database coverage:
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Springer ; DEAL Springer ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---